# A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy

> **NCT06476899** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fei Li** · enrollment: 60 (estimated)

## Conditions studied

- CLL/SLL

## Interventions

- **DRUG:** orelabrutinib
- **DRUG:** FCR/BR
- **DRUG:** BTK inhibitor

## Key facts

- **NCT ID:** NCT06476899
- **Lead sponsor:** Fei Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-24
- **Primary completion:** 2026-03-26
- **Final completion:** 2026-12-26
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06476899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06476899, "A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06476899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*